It has also been reported in ESCC that FOXM1 is significantly elevated in lesion tissue samples of individuals with ESCC and inhibition of FOXM1 can inhibit tumor progression; thus, it can be utilized as a selective target for treatment [22]. The gene discussed is FOXM1; the disease is esophageal squamous cell carcinoma.